Delayed
Hong Kong S.E.
02:43:53 06/05/2024 BST
|
5-day change
|
1st Jan Change
|
6.06
HKD
|
+0.17%
|
|
+3.95%
|
-3.19%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
3,965
|
8,260
|
12,637
|
6,000
|
9,647
|
6,288
|
6,288
|
-
|
Enterprise Value (EV)
1 |
3,545
|
7,744
|
11,951
|
5,172
|
9,026
|
6,383
|
6,086
|
6,089
|
P/E ratio
|
27.2
x
|
31.4
x
|
40.5
x
|
67.2
x
|
48
x
|
35.6
x
|
23.8
x
|
18.6
x
|
Yield
|
0.79%
|
0.87%
|
0.3%
|
0.38%
|
0.61%
|
1.07%
|
1.13%
|
1.49%
|
Capitalization / Revenue
|
6.6
x
|
8.91
x
|
12.2
x
|
7.88
x
|
9.17
x
|
5.84
x
|
4.46
x
|
3.54
x
|
EV / Revenue
|
5.9
x
|
8.36
x
|
11.5
x
|
6.79
x
|
8.58
x
|
5.84
x
|
4.32
x
|
3.43
x
|
EV / EBITDA
|
18.5
x
|
23.1
x
|
27.8
x
|
29.8
x
|
31.2
x
|
23.1
x
|
15.2
x
|
12.3
x
|
EV / FCF
|
65.1
x
|
-
|
99.6
x
|
43.9
x
|
74.5
x
|
53.8
x
|
54.6
x
|
47.6
x
|
FCF Yield
|
1.54%
|
-
|
1%
|
2.28%
|
1.34%
|
1.86%
|
1.83%
|
2.1%
|
Price to Book
|
4.7
x
|
7.32
x
|
6.11
x
|
2.95
x
|
4.3
x
|
2.54
x
|
2.4
x
|
2.15
x
|
Nbr of stocks (in thousands)
|
1,040,475
|
1,052,700
|
1,115,500
|
1,115,700
|
1,115,750
|
1,121,921
|
1,121,921
|
-
|
Reference price
2 |
3.811
|
7.846
|
11.33
|
5.378
|
8.646
|
5.605
|
5.605
|
5.605
|
Announcement Date
|
25/03/19
|
23/03/20
|
22/03/21
|
24/03/22
|
27/03/23
|
26/03/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
600.6
|
926.7
|
1,035
|
761.4
|
1,052
|
1,094
|
1,410
|
1,775
|
EBITDA
1 |
192
|
334.8
|
429.4
|
173.6
|
289.2
|
276.1
|
399.2
|
495.4
|
EBIT
1 |
171.2
|
302.7
|
368.9
|
93.46
|
208.8
|
185.1
|
301.5
|
388
|
Operating Margin
|
28.51%
|
32.66%
|
35.63%
|
12.27%
|
19.85%
|
16.92%
|
21.39%
|
21.85%
|
Earnings before Tax (EBT)
1 |
174.5
|
321.4
|
376.6
|
108.6
|
240.3
|
231.1
|
324.5
|
413
|
Net income
1 |
144.9
|
267
|
314
|
92.62
|
204.8
|
182.1
|
264.4
|
338
|
Net margin
|
24.13%
|
28.81%
|
30.33%
|
12.16%
|
19.46%
|
16.65%
|
18.75%
|
19.04%
|
EPS
2 |
0.1400
|
0.2500
|
0.2800
|
0.0800
|
0.1800
|
0.1600
|
0.2357
|
0.3010
|
Free Cash Flow
1 |
54.46
|
-
|
120
|
117.9
|
121.2
|
97
|
111.5
|
128
|
FCF margin
|
9.07%
|
-
|
11.59%
|
15.48%
|
11.52%
|
7.52%
|
7.91%
|
7.21%
|
FCF Conversion (EBITDA)
|
28.37%
|
-
|
27.95%
|
67.9%
|
41.91%
|
29.67%
|
27.93%
|
25.84%
|
FCF Conversion (Net income)
|
37.58%
|
-
|
38.22%
|
127.26%
|
59.19%
|
38.73%
|
42.17%
|
37.87%
|
Dividend per Share
2 |
0.0300
|
0.0686
|
0.0335
|
0.0204
|
0.0526
|
0.0600
|
0.0633
|
0.0833
|
Announcement Date
|
25/03/19
|
23/03/20
|
22/03/21
|
24/03/22
|
27/03/23
|
26/03/24
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
437.8
|
488.9
|
479
|
556.4
|
447.6
|
313.8
|
531.2
|
520.8
|
648.7
|
445.2
|
649.1
|
760.7
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
-
|
126.8
|
-33.38
|
129.9
|
78.9
|
142.7
|
42.45
|
137.2
|
153.8
|
Operating Margin
|
-
|
-
|
-
|
-
|
28.34%
|
-10.64%
|
24.45%
|
15.15%
|
21.99%
|
9.54%
|
21.14%
|
20.21%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
126
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
23.73%
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-
|
-
|
-
|
-
|
0.1000
|
-
|
0.1100
|
0.0700
|
0.1200
|
0.0400
|
0.1200
|
0.1100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/08/19
|
23/03/20
|
24/08/20
|
22/03/21
|
24/08/21
|
24/03/22
|
30/08/22
|
27/03/23
|
22/08/23
|
26/03/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
420
|
516
|
686
|
828
|
621
|
1,075
|
203
|
200
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
54.5
|
-
|
120
|
118
|
121
|
97
|
112
|
128
|
ROE (net income / shareholders' equity)
|
19.2%
|
27.3%
|
19.9%
|
4.55%
|
9.58%
|
10.5%
|
10.8%
|
12.7%
|
ROA (Net income/ Total Assets)
|
14.9%
|
20.7%
|
15.7%
|
3.56%
|
7.61%
|
9.08%
|
8.69%
|
10%
|
Assets
1 |
975.2
|
1,288
|
2,005
|
2,605
|
2,690
|
2,760
|
3,044
|
3,371
|
Book Value Per Share
2 |
0.8100
|
1.070
|
1.850
|
1.830
|
2.010
|
2.210
|
2.340
|
2.600
|
Cash Flow per Share
2 |
-
|
0.2800
|
0.3400
|
-
|
0.2200
|
0.2000
|
0.3000
|
0.2900
|
Capex
1 |
73.5
|
107
|
100
|
58.8
|
122
|
135
|
177
|
203
|
Capex / Sales
|
12.24%
|
11.54%
|
9.69%
|
7.72%
|
11.57%
|
10.42%
|
12.52%
|
11.43%
|
Announcement Date
|
25/03/19
|
23/03/20
|
22/03/21
|
24/03/22
|
27/03/23
|
26/03/24
|
-
|
-
|
Last Close Price
5.605
CNY Average target price
7.438
CNY Spread / Average Target +32.70% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.19% | 869M | | +9.68% | 125B | | -7.58% | 10.91B | | +2.17% | 8.93B | | +22.75% | 7.57B | | +33.99% | 5.36B | | +8.12% | 3.43B | | -8.48% | 2.81B | | -5.07% | 2.23B | | -4.22% | 2.13B |
Medical Devices & Implants
|